Andrew Kesner, PhD

Preclinical modeling of spontaneous Δ-9-THC withdrawal symptoms in mice: sleep, dopamine, and behavioral maladaptations

April 10th, 1:00PM MST

Dr. Kesner is the Chief of the Unit on Motivation and Arousal at National Institute on Alcohol Abuse and Alcoholism (NIAAA). The mission of his lab is to use systems neuroscience approaches to understand how brain systems controlling motivated behaviors and sleep/arousal processes interact to drive maladaptive behaviors. He earned both his B.A. in Behavioral Biology and Ph.D. in Biology from Johns Hopkins University. Dr. Kesner moved to the National Institute on Alcohol Abuse and Alcoholism (NIAAA) as a Postdoctoral Researcher in Dr. David Lovinger’s Laboratory for Integrative Neuroscience prior to starting his independent lab as an NIH Independent Research Scholar in Fall of 2021.

Previous Webinars

Michael Petersen

Apr 15, 2026 11:00 AM Mountain Time

Trait Modifications in Cannabis Through Engineering and Editing

Michael Petersen has over 40 years of experience as a researcher and mentor in the plant biotech space. He worked for 10 years at Agracetus, a small startup in Wisconsin and then 20 years as a Senior Fellow with Monsanto. Mike stayed […]

Read More »

Francesca Filbey, PhD

Apr 9, 2026 01:00 PM Mountain Time

Understanding Cannabis Use Disorder Through Neuroimaging and Behavior

Francesca Filbey is a Professor and Director of the NeuroImaging of Reward Dynamics Laboratory at the Center for BrainHealth, School of Behavioral and Brain Sciences at The University of Texas at Dallas, and an Adjunct Associate Professor at the University of Texas […]

Read More »

Travis Higginbotham

March 25 at 11:00 AM (MDT)

Turning Science into Cash Flow. Crop production performance and ROI analysis driven by crop science.25

Travis Higginbitham is the Founder & CEO of Due Diligence Horticulture (DDH). He is a horticultural and operations executive with deep experience leading controlled-environment agriculture, cannabis, and ornamental production businesses through innovation, growth, transition, and turnaround. Mr. […]

Read More »

Dr. Yan Wang

12 March, 1:00 PM MST

Real-time and long-term effects of medical marijuana on older adults with chronic pain: Early findings from a prospective cohort study.

 

Yan Wang is an Associate Professor of Epidemiology at the University of Florida (UF). Her research interests focus on leveraging advanced technologies and methods (e.g., wearable sensors, ecological momentary assessment/EMA) to improve […]

Read More »

Igor Grant, M.D. and Thomas Marcotte, Ph.D.

Thursday, February 12th at 1:00 PM MST

The UC San Diego Center for Medicinal Cannabis Research: Some Findings

Igor Grant, MD is Distinguished Professor, and Director of the Center for Medicinal Cannabis Research (CMCR) at the University of California San Diego (UCSD). Established in 2000, the CMCR has been at the forefront of advancing science and policy […]

Read More »

Almut Winterstein, PhD.

Jan 8, 2026 01:00 PM Mountain Time

Clinical research priorities gleaned real-world use patterns: the MEdical Marijuana Outcomes Research repositorY (MEMORY)

Almut Winterstein is Distinguished Professor and the Dr. Robert and Barbara Crisafi Chair for Medication Safety in the Department of Pharmaceutical Outcomes and Policy and in the Department of Epidemiology, and the founding Director of the […]

Read More »